Repros Therapeutics, Inc. (RPRX)

[ThomasS]

Well BioPete, the "clinical path" for Proellex just became clearer for you.
I suspect the CC will include PIII Fibroid details for Proellex as well.

"The first study conducted under the new IND will be..."
" Repros management will hold a conference call to discuss the company's future product clinical development plans, including plans for Proellex in the treatment of uterine fibroids and endometriosis"

Since the PII will use Proellex vs. placebo, the FDA must have been pleased with prior trials, which used active arms.
Most excellent.